IRVINE, Calif., Nov. 12, 2024 – PRISM MediaWire – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today published the following
Conference Call and Webcast on Tuesday, November 12, 2024, at 2:00 p.m. PT / 5:00 p.m. ET IRVINE, Calif., Nov. 6, 2024 – PRISM MediaWire – Oncocyte
MILTON, N.Y., November 4, 2024 – PRISM MediaWire – Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that
PITTSBURGH, PA, November 1, 2024 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (the “Company,” “our” or “us”), a clinical-stage biotechnology company focused on
NEW YORK, October 31, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (“JP3E”) formerly known as Spooz, Inc. (OTC: SPZI), provides an update on
Mankato, MN, October 30, 2024 – PRISM MediaWire – Digital Utilities Ventures (OTC: DUTV) is pleased to announce the significant expansion of its sales force
Tel Aviv, Israel, October 30, 2024 – PRISM MediaWire – HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB Security” or the “Company”), a leading provider of
Thompson Falls, Montana, October 29, 2024 – PRISM MediaWire – United States Antimony Corporation (“USAC” or the “Company”), (NYSE: UAMY), today announced that it will be
New York City, New York, Oct. 29, 2024 – PRISM MediaWire – Holder Resources Inc. (“HRI” or “the Company”), a natural resource company with operations
PITTSBURGH, Pa., Oct. 29, 2024 – PRISM MediaWire – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
